Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults.
Drehobl MA, De Salvo MC, Lewis DE, Breen JD. Drehobl MA, et al. Among authors: de salvo mc. Chest. 2005 Oct;128(4):2230-7. doi: 10.1378/chest.128.4.2230. Chest. 2005. PMID: 16236879 Clinical Trial.
In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study.
D'Urzo AD, De Salvo MC, Ramirez-Rivera A, Almeida J, Sichletidis L, Rapatz G, Kottakis J; FOR-INT-03 Study Group. D'Urzo AD, et al. Chest. 2001 May;119(5):1347-56. doi: 10.1378/chest.119.5.1347. Chest. 2001. PMID: 11348938 Clinical Trial.
Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study.
Swanson RN, Lainez-Ventosilla A, De Salvo MC, Dunne MW, Amsden GW. Swanson RN, et al. Treat Respir Med. 2005;4(1):31-9. doi: 10.2165/00151829-200504010-00004. Treat Respir Med. 2005. PMID: 15725048 Clinical Trial.
Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial.
MacNee W, Allan RJ, Jones I, De Salvo MC, Tan LF. MacNee W, et al. Among authors: de salvo mc. Thorax. 2013 Aug;68(8):738-45. doi: 10.1136/thoraxjnl-2012-202744. Epub 2013 Mar 28. Thorax. 2013. PMID: 23539534 Clinical Trial.
Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2-4 COPD: results from two replicate 48-week studies.
Koch A, Pizzichini E, Hamilton A, Hart L, Korducki L, De Salvo MC, Paggiaro P. Koch A, et al. Among authors: de salvo mc. Int J Chron Obstruct Pulmon Dis. 2014 Jul 5;9:697-714. doi: 10.2147/COPD.S62502. eCollection 2014. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 25045258 Free PMC article. Clinical Trial.
Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.
Zuwallack R, De Salvo MC, Kaelin T, Bateman ED, Park CS, Abrahams R, Fakih F, Sachs P, Pudi K, Zhao Y, Wood CC; Combivent Respimat Inhaler Study Group. Zuwallack R, et al. Among authors: de salvo mc. Respir Med. 2010 Aug;104(8):1179-88. doi: 10.1016/j.rmed.2010.01.017. Epub 2010 Feb 20. Respir Med. 2010. PMID: 20172704 Free article. Clinical Trial.
Liver alterations in antituberculosis regimens containing pyrazinamide.
Pilheu JA, De Salvo MC, Koch O. Pilheu JA, et al. Chest. 1981 Dec;80(6):720-2. doi: 10.1378/chest.80.6.720. Chest. 1981. PMID: 7307595
24 results
Jump to page
Feedback